News

Article

Pharmaceutical Technology

Pharmaceutical Technology-11-01-2001
Volume2001 Supplement
Issue 5

Establishing Compliance of Batch SCADA Systems with FDA CGMP 21 CFR Part 11

Author(s):

Stanley L. Whitman

Batch SCADA systems are assessed for regulatory compliance and functionality.

External Link - article-3381.pdf

Articles in this issue
Maintaining GxP with a 21 CFR Part 11-Compliant Tracking System
Establishing Compliance of Batch SCADA Systems with FDA CGMP 21 CFR Part 11
Toward Twenty-First-Century Sales and Operations Planning
Creating an Integrated Portal for Biological and Chemical Information

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Benjamin McLeod and Sebastian Lykke Skafte Andersen go behind the headlines to examine the motivations behind recent M&A activity, tariff responses, and more.
Related Content
Blockchain for transparent supply chain tracking | Image Credit: ©Andrey -stock.adobe.com
September 4th 2025

Keys to Navigating the Complex Drug Supply Chain

Susan Haigney
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
September 4th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
Question mark background | Image Credit: © Leigh-Prather - © Leigh Prather - stock.adobe.com
September 4th 2025

Effectively Using Contamination Control Strategies

Michelle Heiter Susan J. Schniepp
Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail
September 4th 2025

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
September 4th 2025

Mislabeling Leads to Cyclobenzaprine Hydrochloride Recall

Susan Haigney
New Year, Same Challenges: Pharma’s Ongoing Struggle with FDA 483s
September 4th 2025

New Year, Same Challenges: Pharma’s Ongoing Struggle with FDA 483s

Patrick Falvey Georgia Sloboda Sarah DeDonder Lauren Schoukroun-Barnes
© 2025 MJH Life Sciences

All rights reserved.